457938
Last Update Posted: 2018-10-16
Recruiting has ended
All Genders accepted | 14 Years-70 Years |
4 Estimated Participants | No Expanded Access |
Interventional Study | Does not accept healthy volunteers |
Novel Therapies for Metabolic Complications of Lipodystrophies
Lipodystrophies represent a therapeutic challenge with regards to the management of the diabetes, insulin resistance, hypertriglyceridemia and fatty liver which frequently present in conjunction with significant adipose tissue loss. The purpose of the study and it's four subprojects is to examine the safety and efficacy of various novel interventions designed to improve or resolve the fatty liver, hypertriglyceridemia, and insulin resistance or diabetes that is seen in these patients.
We propose novel therapeutic approaches for the management of metabolic complications in patients with lipodystrophies. The four interventions to be tested are:
Hypothesis 1: An extremely low fat diet.
Eligibility
Relevant conditions:
Insulin Resistance
Hypertriglyceridemia
Diabetes
Hepatic Steatosis
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the trial if you think are close to fitting criteria.
locations
Contact Information
Overall Contact
No valid contacts available
Data sourced from ClinicalTrials.gov